Skip to main content
Log in

A Case of Destructive Polyarthropathy in a 17-Year-Old Youth Following Pefloxacin Treatment

  • Case Report
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Joint and muscle pain have been reported with quinolones; however, arthropathies induced by quinolones do not result in erosive changes in humans, although such changes have occurred in animal studies.

We report an unusual case of destructive polyarthropathy in a 17-year-old boy after treatment with pefloxacin 800 mg/day for 3 months. Pefloxacin may have accentuated the cartilage damage in this case, even if an underlying joint disease could not be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bailey RR, Natale R, Linton AL. Nalidixic acid arthralgia. Canadian Medical Association Journal 107: 604, 1972

    PubMed  Google Scholar 

  • Boerema JBJ, Pauwels R, Scheeper SJ, Grombach W. Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections. Antimicrobial Agents and Chemotherapy 17(B): 103–109, 1986

    Google Scholar 

  • Cassidy JT. Juvenile rheumatoid arthritis. In Kelley et al. (Eds) Textbook of Rheumatology, pp. 1289–1311, 3rd edition, Saunders Company, Philadelphia, 1989

    Google Scholar 

  • Chevais M, Reinert P, Rondeau MC, Tobelem R, Albengres E, et al. Critical risk/benefit analysis of pefloxacin use in children under 15 years: the problem of arthralgias. International Journal of Clinical Pharmacology Therapy and Toxicology 25: 306–309, 1987

    CAS  Google Scholar 

  • Dellamonica P, Bernard E, Etesse M, Garaffo R. The diffusion of pefloxacin into bone and the treatment of osteomyelitis. Antimicrobial Agents and Chemotherapy 17(B): 93–102, 1986

    Google Scholar 

  • Fast A, Alon M, Weiss S, Zer-Aviv F. Avascular necrosis of bone following short-term dexamethasone therapy for brain oedema. Journal of Neurosurgery 61: 983, 1984

    Article  PubMed  CAS  Google Scholar 

  • Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses and toxicities in humans. Antimicrobial Agents and Chemotherapy 28: 716–721, 1985

    Article  PubMed  CAS  Google Scholar 

  • Jorgensen C, Anaya JM, Didry C, Canovas F, Serre I, et al. Arthropathies et tendinopathies achilléennes induites par la péfloxacine. A propos d’une observation. Revue du Rhumatisme et des Maladies Osteo-Articulaires 58: 623–625, 1991

    PubMed  CAS  Google Scholar 

  • Kato M, Onodeia T. Morphological investigation of osteochondritis induced by ofloxacin in rats. Fundamental and Applied Toxicology 11: 120–131, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kesseler A, Lacassie A, Hugot JP, Talon Ph, Thomas D, et al. Arthropathies consécutives à l’adminiostration de pefloxacinechez un adolescent atteint de mucoviscidose. Annales de Pediatrie 36: 275–278, 1989

    PubMed  CAS  Google Scholar 

  • Mc Evans JR, Davey PG. Ciprofloxacin and tenosynovitis. Lancet 2: 900, 1988

    Google Scholar 

  • Maroteaux P. Epiphyseal dysplasia multiple. In Bergsma D. (Ed.) Birth defects compendium, p. 409, National Foundation, March of Dimes, Alan R. Liss Inc., New York, 1979

    Google Scholar 

  • Schulter G. Ciprofloxacin: review of potential toxicological effects. American Journal of Medicine 82(Suppl. 4A): 91–93, 1987

    Google Scholar 

  • Sthalmann R, Merker HJ, Hinz N, Chahoud I, Webb J, et al. Ofloxacin in juvenile non-human primates and rats: arthropathia and drug plasma concentrations. Archives of Toxicology 64: 193–204, 1980

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chevalier, X., Albengres, E., Voisin, MC. et al. A Case of Destructive Polyarthropathy in a 17-Year-Old Youth Following Pefloxacin Treatment. Drug-Safety 7, 310–314 (1992). https://doi.org/10.2165/00002018-199207040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199207040-00007

Keywords

Navigation